Karlsruhe, Germany

Erika Von Mullendorff

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1978.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erika Von Mullendorff. Retrieved from https://idiyas.com/inventor/erika-von-mullendorff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Erika Von Mullendorff

Introduction

Erika Von Mullendorff is a notable inventor based in Karlsruhe, Germany. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work at Boehringer Mannheim GmbH. Her expertise and creativity have led to the development of unique compounds that have potential applications in medicine.

Latest Patents

One of her most recognized patents is for the compound 9-[3-(4-Phenoxymethylpiperidino)-propyl]-adenines. This invention is characterized by the formula ##STR1##, wherein R.sub.1 is a hydrogen atom or a lower alkyl radical. This patent showcases her ability to create complex chemical structures that may have therapeutic benefits.

Career Highlights

Throughout her career, Erika has demonstrated a strong commitment to research and development. Her work at Boehringer Mannheim GmbH has positioned her as a key player in the pharmaceutical industry. With a total of 1 patent to her name, she continues to push the boundaries of innovation in her field.

Collaborations

Erika has collaborated with esteemed colleagues such as Walter-Gunar Friebe and Max Thiel. These partnerships have allowed her to enhance her research and contribute to the advancement of pharmaceutical sciences.

Conclusion

Erika Von Mullendorff is a pioneering inventor whose work has the potential to impact the pharmaceutical industry significantly. Her dedication to innovation and collaboration exemplifies the spirit of scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…